Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.
Raney RB, Meza J, Anderson JR, Fryer CJ, Donaldson SS, Breneman JC, Fitzgerald TJ, Gehan EA, Michalski JM, Ortega JA, Qualman SJ, Sandler E, Wharam MD, Wiener ES, Maurer HM, Crist WM. Raney RB, et al. Among authors: ortega ja. Med Pediatr Oncol. 2002 Jan;38(1):22-32. doi: 10.1002/mpo.1259. Med Pediatr Oncol. 2002. PMID: 11835233
Activity of intraarterial carboplatin as a single agent in the treatment of newly diagnosed extremity osteosarcoma.
Petrilli AS, Kechichian R, Broniscer A, Garcia RJ, Tanaka C, Francisco J, Lederman H, Odone Filho V, Camargo OP, Bruniera P, Pericles P, Consentino E, Ortega JA. Petrilli AS, et al. Among authors: ortega ja. Med Pediatr Oncol. 1999 Aug;33(2):71-5. doi: 10.1002/(sici)1096-911x(199908)33:2<71::aid-mpo2>3.0.co;2-t. Med Pediatr Oncol. 1999. PMID: 10398179 Clinical Trial.
Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival.
Petrilli AS, de Camargo B, Filho VO, Bruniera P, Brunetto AL, Jesus-Garcia R, Camargo OP, Pena W, Péricles P, Davi A, Prospero JD, Alves MT, Oliveira CR, Macedo CR, Mendes WL, Almeida MT, Borsato ML, dos Santos TM, Ortega J, Consentino E; Brazilian Osteosarcoma Treatment Group Studies III and IV. Petrilli AS, et al. J Clin Oncol. 2006 Mar 1;24(7):1161-8. doi: 10.1200/JCO.2005.03.5352. J Clin Oncol. 2006. PMID: 16505436 Clinical Trial.
Discovery of CDC42 Inhibitors with a Favorable Pharmacokinetic Profile and Anticancer In Vivo Efficacy.
Brindani N, Vuong LM, La Serra MA, Salvador N, Menichetti A, Acquistapace IM, Ortega JA, Veronesi M, Bertozzi SM, Summa M, Girotto S, Bertorelli R, Armirotti A, Ganesan AK, De Vivo M. Brindani N, et al. Among authors: ortega ja. J Med Chem. 2024 Jun 27;67(12):10401-10424. doi: 10.1021/acs.jmedchem.4c00855. Epub 2024 Jun 12. J Med Chem. 2024. PMID: 38866385 Free PMC article.
CLIP-Seq analysis enables the design of protective ribosomal RNA bait oligonucleotides against C9ORF72 ALS/FTD poly-GR pathophysiology.
Ortega JA, Sasselli IR, Boccitto M, Fleming AC, Fortuna TR, Li Y, Sato K, Clemons TD, Mckenna ED, Nguyen TP, Anderson EN, Asin J, Ichida JK, Pandey UB, Wolin SL, Stupp SI, Kiskinis E. Ortega JA, et al. Sci Adv. 2023 Nov 10;9(45):eadf7997. doi: 10.1126/sciadv.adf7997. Epub 2023 Nov 10. Sci Adv. 2023. PMID: 37948524 Free PMC article.
Isolation and Characterization of Monomeric Human RAD51: A Novel Tool for Investigating Homologous Recombination in Cancer.
Rinaldi F, Schipani F, Balboni B, Catalano F, Marotta R, Myers SH, Previtali V, Veronesi M, Scietti L, Cecatiello V, Pasqualato S, Ortega JA, Girotto S, Cavalli A. Rinaldi F, et al. Among authors: ortega ja. Angew Chem Int Ed Engl. 2023 Dec 18;62(51):e202312517. doi: 10.1002/anie.202312517. Epub 2023 Nov 20. Angew Chem Int Ed Engl. 2023. PMID: 37924230
201 results